Surgery for benign insulinoma: An international review | Zendy

Rothmund Matthias | Zendy; Angelini Lucio | Zendy; Brunt L. Michael | Zendy; Farndon John R. | Zendy; Geelhoed Glenn | Zendy; Grama Dimitrie | Zendy; Herfarth Christian | Zendy; Kaplan Edwin L. | Zendy; Largiader Felix | Zendy; Morino Francesco | Zendy; Peiper HansJürgen | Zendy; Proye Charles | Zendy; Röher HansDietrich | Zendy; Rückert Klaus | Zendy; Kümmerle Fritz | Zendy; Thompson Norman W. | Zendy; van Heerden Jon A. | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Surgery for benign insulinoma: An international review

Author(s) -

Rothmund Matthias,

Angelini Lucio,

Brunt L. Michael,

Farndon John R.,

Geelhoed Glenn,

Grama Dimitrie,

Herfarth Christian,

Kaplan Edwin L.,

Largiader Felix,

Morino Francesco,

Peiper HansJürgen,

Proye Charles,

Röher HansDietrich,

Rückert Klaus,

Kümmerle Fritz,

Thompson Norman W.,

van Heerden Jon A.

Publication year - 1990

Publication title -

world journal of surgery

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.115

H-Index - 148

eISSN - 1432-2323

pISSN - 0364-2313

DOI - 10.1007/bf01658536

Subject(s) - medicine , surgery , cardiothoracic surgery , abdominal surgery , vascular surgery , cardiac surgery , insulinoma , general surgery , pancreas

In a multiinstitutional review, data on 396 patients with benign solitary or multiple insulinomas operated on in 15 centers were collected. In these 396 patients, 419 laparotomies (375 primary procedures and 44 reoperations) were performed. The rate of unnecessary laparotomies was 1.7%. Complications occurred after 132 operations (31.5%), requiring 27 reinterventions (6.4%). Ten (2%) patients died within 30 days of surgery. The success rate of first procedures in the centers was 94.9%. After reoperation, all but 2 (99.5%) of these patients were cured. The overall cure rate including those patients who had their primary operations elsewhere was 97.5% .

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research